[Prognostic evaluation of heart-liver ratio of (99m)Tc-MIBI on liver cirrhosis].
OBJECTIVE
To evaluate heart-liver ratio (H/L) of (99m)Tc-MIBI on the prognosis of cirrhotic patients.


METHODS
Retrospective cohort study was used to analyze the survival rate among the patients who had received H/L detection, and the H/L value was classified by Child-Pugh class.


RESULTS
All the patients were followed up for 0.1 to 63 months. H/L ratio was significantly different among Child-Pugh A, B, C groups (0.85 +/- 0.15, 0.99 +/- 0.19, 1.15 +/- 0.27, F=5.09, P<0.01); 6-month, 1-year, and 2-year survival rates in H/L<1.0 group were significantly higher than those in H/L>1.0 group (85.9%, 57.4%, 57. 4% vs 50.0%, 39.4%, 19.7%, P<0.01 ). Among patients with Child-Pugh degree C, 6-month, 1-year, and 2-year survival rates in H/L<1.0 group were significantly higher than those in H/L>1.0 group (71.4%, 42.9%, 42.9% vs 27.3%, 18.2%, 0).


CONCLUSIONS
H/L is an effective index for evaluating prognosis of cirrhotic patients, and it could be complemented by Child-Pugh classification.
Zhang
Y
Y
Department of Gastroenterology, Zhongshan Hospital, Shanghai Medical University, Shanghai 200032, China.
Liu
T
T
Chen
S
S
Wang
J
J
D000328:Adult; D000368:Aged; D005260:Female; D006321:Heart / Q000000981:diagnostic imaging*; D006801:Humans; D008099:Liver / Q000000981:diagnostic imaging*; D008103:Liver Cirrhosis / Q000000981:diagnostic imaging* / Q000401:mortality; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D011877:Radionuclide Imaging; D015996:Survival Rate; D017256:Technetium Tc 99m Sestamibi
D017256:Technetium Tc 99m Sestamibi